Publikationen von 0000-0002-8673-5133
(ORCID: 0000-0002-8673-5133)
 | Eine Stufe nach oben |
Anzahl der Einträge: 6.
2014
Infantino, Maria, Manfredi, Mariangela, Meacci, Francesca, Sarzi-Puttini, Piercarlo 
, Ricci, Cristian, Atzeni, Fabiola und Benucci, Maurizio
(2014)
Anti-citrullinated peptide antibodies and rheumatoid factor isotypes in the diagnosis of rheumatoid arthritis: an assessment of combined tests.
Clinica Chimica Acta 436, S. 237-242.
Volltext nicht vorhanden.
, Ricci, Cristian, Atzeni, Fabiola und Benucci, Maurizio
(2014)
Anti-citrullinated peptide antibodies and rheumatoid factor isotypes in the diagnosis of rheumatoid arthritis: an assessment of combined tests.
Clinica Chimica Acta 436, S. 237-242.
Volltext nicht vorhanden.
2008
Straub, Rainer H. , Pongratz, Georg , Cutolo, Maurizio, Wijbrandts, Carla A., Baeten, Dominique, Fleck, Martin, Atzeni, Fabiola, Grunke, Mathias, Kalden, Joachim R., Schölmerich, Jürgen, Lorenz, Hanns‐Martin, Tak, Paul P. und Sarzi‐Puttini, Piercarlo
(2008)
Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti–tumor necrosis factor therapy in rheumatoid arthritis.
Arthritis & Rheumatism 58 (4), S. 976-984.
Volltext nicht vorhanden.
, Pongratz, Georg , Cutolo, Maurizio, Wijbrandts, Carla A., Baeten, Dominique, Fleck, Martin, Atzeni, Fabiola, Grunke, Mathias, Kalden, Joachim R., Schölmerich, Jürgen, Lorenz, Hanns‐Martin, Tak, Paul P. und Sarzi‐Puttini, Piercarlo
(2008)
Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti–tumor necrosis factor therapy in rheumatoid arthritis.
Arthritis & Rheumatism 58 (4), S. 976-984.
Volltext nicht vorhanden.
2006
Sarzi-Puttini, P. , Atzeni, F., Schölmerich, J., Cutolo, M. und Straub, R. H.
(2006)
Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3.
Annals of the rheumatic diseases 65 (3), S. 301-5.
Zugang zum Volltext eingeschränkt.
, Atzeni, F., Schölmerich, J., Cutolo, M. und Straub, R. H.
(2006)
Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3.
Annals of the rheumatic diseases 65 (3), S. 301-5.
Zugang zum Volltext eingeschränkt.
Härle, P., Straub, R. H. , Wiest, R., Mayer, A., Schölmerich, J., Atzeni, F., Carrabba, M., Cutolo, M. und Sarzi-Puttini, P.
(2006)
Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems.
Annals of the rheumatic diseases 65 (1), S. 51-6.
Zugang zum Volltext eingeschränkt.
, Wiest, R., Mayer, A., Schölmerich, J., Atzeni, F., Carrabba, M., Cutolo, M. und Sarzi-Puttini, P.
(2006)
Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems.
Annals of the rheumatic diseases 65 (1), S. 51-6.
Zugang zum Volltext eingeschränkt.
Straub, Rainer H., Härle, Peter, Sarzi‐Puttini, Piercarlo und Cutolo, Maurizio
(2006)
Tumor necrosis factor–neutralizing therapies improve altered hormone axes: An alternative mode of antiinflammatory action.
Arthritis & Rheumatism 54 (7), S. 2039-2046.
Volltext nicht vorhanden.
und Cutolo, Maurizio
(2006)
Tumor necrosis factor–neutralizing therapies improve altered hormone axes: An alternative mode of antiinflammatory action.
Arthritis & Rheumatism 54 (7), S. 2039-2046.
Volltext nicht vorhanden.
2005
Straub, R H , make_name_string expected hash reference , make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference und make_name_string expected hash reference
(2005)
Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol.
Annals of the Rheumatic Diseases 64 (9), S. 1353-1356.
Volltext nicht vorhanden.
, make_name_string expected hash reference , make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference und make_name_string expected hash reference
(2005)
Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol.
Annals of the Rheumatic Diseases 64 (9), S. 1353-1356.
Volltext nicht vorhanden.